Condition
Cardiovascular Kidney Metabolic Syndrome
Total Trials
4
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Not Yet Recruiting2
Active Not Recruiting1
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07718789Not Yet RecruitingPrimary
Cardiovascular-Kidney-Metabolic Syndrome Registry
NCT07577284Not ApplicableNot Yet RecruitingPrimary
AI Chatbot-Enabled ePRO Symptom Monitoring and Self-Management for Early Cardiovascular-Kidney-Metabolic Syndrome
NCT07027995Not ApplicableRecruitingPrimary
Food and Fitness With Medicine (FFWM)
NCT07188545Active Not RecruitingPrimary
Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)
Showing all 4 trials